[基因治疗与核酸类药物研发的障碍与途径] - Suppr

[Obstacles and approaches to the development of gene therapy and nucleic acid-based drug].

作者信息

Shimizu Kahori, Ando Mitsuru

机构信息

Laboratory of Biochemistry and Molecular Biology, Graduate School of Pharmaceutical Sciences, Osaka University, Osaka, Japan.

出版信息

Yakugaku Zasshi. 2012;132(12):1371-2. doi: 10.1248/yakushi.12-00235-f.

DOI:10.1248/yakushi.12-00235-f

PMID:23208043

Abstract

摘要

相似文献

[Obstacles and approaches to the development of gene therapy and nucleic acid-based drug].

Yakugaku Zasshi. 2012;132(12):1371-2. doi: 10.1248/yakushi.12-00235-f.

Relieving bottlenecks in RNA drug discovery for retinal diseases.

Adv Exp Med Biol. 2012;723:145-53. doi: 10.1007/978-1-4614-0631-0_20.

Identification of disease-relevant genes for molecularly-targeted drug discovery.

Curr Cancer Drug Targets. 2012 Jan;12(1):1-13. doi: 10.2174/156800912798888947.

Tumour-agnostic therapies.

Nat Rev Drug Discov. 2020 Jun;19(6):383-384. doi: 10.1038/d41573-020-00015-1.

Editorial: a new era of gene therapy.

Curr Top Med Chem. 2012;12(15):1593. doi: 10.2174/156802612803531441.

Synthetic nucleic acid nanomedicines: A Chinese perspective.

J Gene Med. 2019 Jul;21(7):e3111. doi: 10.1002/jgm.3111.

[Innovative approach for drug discovery by targeted therapy].

Yakugaku Zasshi. 2013;133(1):41-2. doi: 10.1248/yakushi.12-00245-f.

[DDS technology for development of gene therapy and nucleic acid drug. Foreword].

Yakugaku Zasshi. 2008 Nov;128(11):1557-8. doi: 10.1248/yakushi.128.1557.

Synthetic delivery systems for intravenous administration of nucleic acids.

Nanomedicine (Lond). 2007 Apr;2(2):169-81. doi: 10.2217/17435889.2.2.169.

Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy.

Med Res Rev. 2018 May;38(3):829-869. doi: 10.1002/med.21479. Epub 2018 Jan 5.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Obstacles and approaches to the development of gene therapy and nucleic acid-based drug].

Yakugaku Zasshi. 2012;132(12):1371-2. doi: 10.1248/yakushi.12-00235-f.

Relieving bottlenecks in RNA drug discovery for retinal diseases.

Adv Exp Med Biol. 2012;723:145-53. doi: 10.1007/978-1-4614-0631-0_20.

Identification of disease-relevant genes for molecularly-targeted drug discovery.

Curr Cancer Drug Targets. 2012 Jan;12(1):1-13. doi: 10.2174/156800912798888947.

Tumour-agnostic therapies.

Nat Rev Drug Discov. 2020 Jun;19(6):383-384. doi: 10.1038/d41573-020-00015-1.

Editorial: a new era of gene therapy.

Curr Top Med Chem. 2012;12(15):1593. doi: 10.2174/156802612803531441.

Synthetic nucleic acid nanomedicines: A Chinese perspective.

J Gene Med. 2019 Jul;21(7):e3111. doi: 10.1002/jgm.3111.

[Innovative approach for drug discovery by targeted therapy].

Yakugaku Zasshi. 2013;133(1):41-2. doi: 10.1248/yakushi.12-00245-f.

[DDS technology for development of gene therapy and nucleic acid drug. Foreword].

Yakugaku Zasshi. 2008 Nov;128(11):1557-8. doi: 10.1248/yakushi.128.1557.

Synthetic delivery systems for intravenous administration of nucleic acids.

Nanomedicine (Lond). 2007 Apr;2(2):169-81. doi: 10.2217/17435889.2.2.169.

Chemical modifications of nucleic acid drugs and their delivery systems for gene-based therapy.

Med Res Rev. 2018 May;38(3):829-869. doi: 10.1002/med.21479. Epub 2018 Jan 5.

[Obstacles and approaches to the development of gene therapy and nucleic acid-based drug].

作者信息

机构信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献